Psychopharmacology of olanzapine - A review

被引：49

作者：

Stephenson, CME ^{[1
]}

Pilowsky, LS ^{[1
]}

机构：

[1] Inst Psychiat, London, England

来源：

BRITISH JOURNAL OF PSYCHIATRY | 1999年 / 174卷

关键词：

D O I：

10.1192/S0007125000298115

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：52 / 58

页数：7

共 61 条

[1]

[Anonymous], 1981, Scale for the Assessment of Negative Symptoms (SANS)

[2] ANTAGONISM OF PHENCYCLIDINE-INDUCED DEFICITS IN PREPULSE INHIBITION BY THE PUTATIVE ATYPICAL ANTIPSYCHOTIC OLANZAPINE [J].

BAKSHI, VP ;

GEYER, MA .

PSYCHOPHARMACOLOGY, 1995, 122 (02) :198-201

[3]

Baldacchino AM., 1998, PHARM J, V260, P207

[4] FIRST CLINICAL-EXPERIENCE WITH OLANZAPINE (LY-170053) - RESULTS OF AN OPEN-LABEL SAFETY AND DOSE-RANGING STUDY IN PATIENTS WITH SCHIZOPHRENIA [J].

BALDWIN, DS ;

MONTGOMERY, SA .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 (04) :239-244

[5]

Beasley CM, 1997, J CLIN PSYCHIAT, V58, P13

[6] Olanzapine versus placebo: Results of a double-blind, fixed-dose olanzapine trial [J].

Beasley, CM ;

Sanger, T ;

Satterlee, W ;

Tollefson, G ;

Tran, P ;

Hamilton, S ;

Green, A ;

Dott, S ;

Pfister, G ;

Roxas, L ;

Small, J ;

Thomas, M ;

Ames, D ;

Schooler, N ;

Baker, R ;

Levine, R ;

Fabre, L ;

Friedel, R ;

Safferman, A ;

Lieberman, J ;

Stahl, S .

PSYCHOPHARMACOLOGY, 1996, 124 (1-2) :159-167

[7] Olanzapine versus haloperidol: Acute phase results of the international double-blind olanzapine trial [J].

Beasley, CM ;

Hamilton, SH ;

Crawford, AM ;

Dellva, MA ;

Tollefson, GD ;

Tran, PV ;

Blin, O ;

Beuzen, JN .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1997, 7 (02) :125-137

[8] Olanzapine versus placebo and haloperidol - Acute phase results of the North American double-blind olanzapine trial [J].

Beasley, CM ;

Tollefson, G ;

Tran, P ;

Satterlee, W ;

Sanger, T ;

Hamilton, S ;

Fabre, L ;

Small, J ;

Ereshefsky, L ;

True, J ;

Nemeroff, C ;

Risch, SC ;

Perry, PJ ;

Potkin, SG ;

Borison, RL ;

James, S ;

Meltzer, HY ;

Iqbal, N ;

Fann, WE ;

Gewirtz, GR ;

Landbloom, R ;

RoyByrne, PP ;

Tuason, VB ;

Carman, JS ;

Stokes, PE ;

Williams, R ;

Ancill, RJ ;

MacEwan, GW ;

Gujavarty, KS ;

Jones, B ;

Lohr, JB .

NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) :111-123

[9]

Beasley CM, 1997, J CLIN PSYCHIAT, V58, P7

[10]

Bergstrom R. F., 1995, Pharmaceutical Research (New York), V12, pS358

← 1 2 3 4 5 6 7 →